Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John S Albin, M.D., Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. ALBIN19F0 (Albin, John Squire) Nov 1, 2019 - Oct 31, 2021
    Cystic Fibrosis Foundation
    Peptide Chemistry for the Development of Novel Antimicrobial Agents
    Role: Principal Investigator
  2. F30DA026310 (ALBIN, JOHN SQUIRE) May 25, 2009 - May 24, 2013
    Determining the Role of APOBEC3 Proteins in HIV-1 Drug Resistance
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Queen J, Karaba S, Albin J, Karaba A, Howard-Anderson J, Skinner N, Herman JD, Paras ML, Melia MT. The Time is Now: A Call for Renewed Support of Infectious Disease Physician-Scientist Trainees in the COVID-19 Era. J Infect Dis. 2021 Mar 26. PMID: 33770174.
    Citations:    Fields:    
  2. Dugdale CM, Rubins DM, Lee H, McCluskey SM, Ryan ET, Kotton CN, Hurtado RM, Ciaranello AL, Barshak MB, McEvoy DS, Nelson SB, Basgoz N, Lazarus JE, Ivers LC, Reedy JL, Hysell KM, Lemieux JE, Heller HM, Dutta S, Albin JS, Brown TS, Miller AL, Calderwood SB, Walensky RP, Zachary KC, Hooper DC, Hyle EP, Shenoy ES. COVID-19 Diagnostic Clinical Decision Support: a Pre-Post Implementation Study of CORAL (COvid Risk cALculator). Clin Infect Dis. 2021 Feb 10. PMID: 33564833.
    Citations: 2     Fields:    
  3. Albin JS, Pentelute BL. Efficient flow synthesis of human antimicrobial peptides. Aust J Chem. 2020 Apr; 73(4):380-388. PMID: 32431323.
  4. Ikeda T, Symeonides M, Albin JS, Li M, Thali M, Harris RS. HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G. PLoS Pathog. 2018 04; 14(4):e1007010. PMID: 29677220.
    Citations: 13     Fields:    Translation:HumansCells
  5. Richards C, Albin JS, Demir Ö, Shaban NM, Luengas EM, Land AM, Anderson BD, Holten JR, Anderson JS, Harki DA, Amaro RE, Harris RS. The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches. Cell Rep. 2015 Dec 01; 13(9):1781-8. PMID: 26628363.
    Citations: 21     Fields:    Translation:HumansCells
  6. Land AM, Shaban NM, Evans L, Hultquist JF, Albin JS, Harris RS. APOBEC3F determinants of HIV-1 Vif sensitivity. J Virol. 2014 Nov; 88(21):12923-7. PMID: 25142588.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  7. Albin JS, Brown WL, Harris RS. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. Virology. 2014 Feb; 450-451:49-54. PMID: 24503066.
    Citations: 11     Fields:    Translation:HumansCells
  8. Bohn MF, Shandilya SM, Albin JS, Kouno T, Anderson BD, McDougle RM, Carpenter MA, Rathore A, Evans L, Davis AN, Zhang J, Lu Y, Somasundaran M, Matsuo H, Harris RS, Schiffer CA. Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. Structure. 2013 Jun 04; 21(6):1042-50. PMID: 23685212.
    Citations: 58     Fields:    Translation:Cells
  9. Albin JS, Anderson JS, Johnson JR, Harjes E, Matsuo H, Krogan NJ, Harris RS. Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F. J Mol Biol. 2013 Apr 12; 425(7):1172-82. PMID: 23318957.
    Citations: 14     Fields:    Translation:HumansCells
  10. Albin JS, Harris RS. Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success, Eds. Stuart LeGrice and Matthias Gotte. APOBECs and Their Role in Proviral DNA Synthesis. 2013; 253-280. View Publication.
  11. Albin JS, LaRue RS, Weaver JA, Brown WL, Shindo K, Harjes E, Matsuo H, Harris RS. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. J Biol Chem. 2010 Dec 24; 285(52):40785-92. PMID: 20971849.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  12. Albin JS, Haché G, Hultquist JF, Brown WL, Harris RS. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. J Virol. 2010 Oct; 84(19):10209-19. PMID: 20686027.
    Citations: 34     Fields:    Translation:HumansCells
  13. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010 Jul; 38(13):4274-84. PMID: 20308164.
    Citations: 198     Fields:    Translation:HumansCells
  14. Albin JS, Harris RS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med. 2010 Jan 22; 12:e4. PMID: 20096141.
    Citations: 110     Fields:    Translation:HumansCells
  15. Haché G, Shindo K, Albin JS, Harris RS. Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Curr Biol. 2008 Jun 03; 18(11):819-24. PMID: 18501607.
    Citations: 51     Fields:    Translation:HumansCells
  16. Sundaram P, Han W, Cohen N, Echalier B, Albin J, Timmons L. Caenorhabditis elegans ABCRNAi transporters interact genetically with rde-2 and mut-7. Genetics. 2008 Feb; 178(2):801-14. PMID: 18245353.
    Citations: 6     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Albin's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (73)
Co-Authors (23)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.